CDKN2A and melanoma: In summary, rare mutations in high-penetrance genes account for melanoma manifestation in approximately 22% of melanoma families (19% for CDKN2A, and 3% for the other genes), while the major melanoma genetic factors underlying melanoma in prone families are still unknown [39].